You are here:
Sun Pharma
#

Sun Pharma

Get Alerts

Articles

View all

Nifty breaches 7,700 mark, Sensex at new high on fund inflows

Jun 11, 2014

Nifty breaches 7,700 mark, Sensex at new high on fund inflows

The NSE index Nifty today crossed the 7,700 level for the first time and the BSE Sensex hit yet another record high of 25,735.87 led by a rally in IT, auto banking and pharma stocks on sustained inflow of foreign capital. #Sensex #BSE Sensex #India #TCS #wipro #nifty #NewsTracker #Sun Pharma #markets #Hang Seng Index
Andhra HC vacates status quo order on Sun Pharma-Ranbaxy merger

May 24, 2014

Andhra HC vacates status quo order on Sun Pharma-Ranbaxy merger

The Andhra Pradesh High Court on Saturday vacated the status quo order it had issued earlier on the merger process between Sun Pharma and Ranbaxy. #Sensex #India #NewsTracker #Sun Pharma #BSE #Ranbaxy #Andhra Pradesh High Court
Decide on Ranbaxy-Sun Pharma merger in 2 days: SC to Andhra HC

May 21, 2014

Decide on Ranbaxy-Sun Pharma merger in 2 days: SC to Andhra HC

The pharmaceutical giants approached the court seeking its direction to vacate interim order on the High Court which had on 25 April stayed the merger and ordered status quo. #India #Business #NewsTracker #Sun Pharma #Supreme Court #pharmaceuticals #Ranbaxy #Merger #Andhra High Court
Nearly 30,000 packs of allergy-relief drug recalled by Ranbaxy in US

May 02, 2014

Nearly 30,000 packs of allergy-relief drug recalled by Ranbaxy in US

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches #World #India #US #NewsTracker #Dr Reddy's #Sun Pharma #pharmaceuticals #Ranbaxy #US FDA #DCGI #Exporting medicines #ban on Indian pharma drugs
Decoder: What Sun Pharma's $4 bn buyout of Ranbaxy is all about

Apr 07, 2014

Decoder: What Sun Pharma's $4 bn buyout of Ranbaxy is all about

The combination of the two will create the fifth-largest generic pharma company in the world and the largest pharmaceutical company in India and leave Daiichi Sankyo with a significant stake in the combined entity. #deal #Sun Pharma #Ranbaxy #Daiichi Sankyo #Pharmaceutical company

BLOG POSTS

View all

Flop show? Indian pharma rolls back its drug discovery ambitions

May 09, 2011

Flop show? Indian pharma rolls back its drug discovery ambitions

Indian pharmaceutical companies have tried to speed up drug discoveries by hiving research off into separate companies. But as the Piramal decision shows, they are re-merging these companies. Has the strategy failed? #Piramal Healthcare #Dr Reddy's #Sun Pharma #Drug research #NCEs #CorporateStrategy

Wire

View all

Flop show? Indian pharma rolls back its drug discovery ambitions

Jul 31, 2014

John Lennon Said It Best: 'Living Is Easy With Eyes Closed'

I was floored by this Saturday's New York Times article , "Seeing a Supersize Yacht as a Job Engine, Not a Self-Indulgence." I was amazed not only by how the subject of the article, Mr. Jones, rationalized his extraordinary consumption habits, but al... #John Lennon #Larry Ellison #Paul Allen #David Geffen #New York Times Company
Flop show? Indian pharma rolls back its drug discovery ambitions

Jul 17, 2014

'While it didn't work out for me I just had to take my chance'

Wednesday July 16 – Stage 11: Besancon to Oyonnax (187.5km) After a week of rain the sun finally came out on the Tour this morning and I began today's stage in 25 degrees. I began the stage in a brand new jersey, shorts and socks and was looking forw... #John Lennon #Larry Ellison #Paul Allen #David Geffen #New York Times Company
Flop show? Indian pharma rolls back its drug discovery ambitions

Jul 12, 2014

Italian still leads Tour that's more crash than dash

NANCY, France -- Matteo Trentin of Italy won Friday's seventh stage of the Tour de France in a photo finish after two top American hopefuls went down in the latest spills of a crash-marred edition this year. Fellow Italian Vincenzo Nibali retained th... #Simon Gerrans #Cannondale Bicycle Corporation #Mark Cavendish #Vincenzo Nibali #Tony Gallopin